Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

Dyadic and Medytox team up on vaccines targeting COVID-19 variants

By Brian Buntz | March 24, 2021

Dyadic and MedytoxThe Korean biopharma Medytox and Jupiter, Fla.–based Dyadic International are partnering to develop vaccines that would protect against multiple COVID-19 variants.

The companies plan on using Dyadic’s C1-cell protein production platform in the development of the vaccines.

The vaccines would use a similar strategy to flu vaccines, which are often trivalent or quadrivalent. The former is designed to afford protection against three virus types, while the latter targets four viruses.

Medytox has explored other gene expression platforms and has concluded that the fungi-derived C1 expression system is “the most realistic technology to develop and manufacture multi-valent (i.e., tri-valent, and tetra-valent) vaccines, rapidly and affordably, against COVID-19 mutant viruses without the need for a large-scale bioreactor facility,” said Gi-Hyeok Yang, head of R&D at Medytox, in a press release.

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Johnson & Johnson
Feds halt J&J COVID-19 vaccine due to blood clot concern
pharmaceuticals
Analyzing FDA guidance on DDI studies for therapeutic proteins
mouse
When can computer models replace animal trials?
Intravacc
Intravacc touts preclinical, non-human results for COVID-19 nasal spray vaccine

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards